Arca biopharma establishes special committee of the board of directors

Westminster, colo., april 18, 2022 (globe newswire) -- arca biopharma, inc. (nasdaq: abio), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that its board of directors has established a special committee to evaluate strategic options for maximizing stockholder value.   the company believes there are multiple potential opportunities to enhance value for arca stockholders. the special committee includes arca board chairman robert e. conway (chair), and board members linda grais, m.d. and anders hove, m.d.
ABIO Ratings Summary
ABIO Quant Ranking